Skip to main content

Vir Biotechnology, Inc.

VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001706431

No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Vir Biotechnology, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
214
+12 vs. Q1 2022
Shares held
85.8M
+4.94M (+6.1%) vs. Q1 2022
Total value
$2.20B
+$120.1M (+5.8%) vs. Q1 2022
New holders
51
76 more added
Sold out
39
58 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 214 institutions
Q1 2021: 157 institutionsQ2 2021: 166 institutionsQ3 2021: 175 institutionsQ4 2021: 210 institutionsQ1 2022: 204 institutionsQ2 2022: 214 institutionsQ3 2022: 221 institutionsQ4 2022: 225 institutionsQ1 2023: 234 institutionsQ2 2023: 227 institutionsQ3 2023: 215 institutionsQ4 2023: 207 institutionsQ1 2024: 210 institutionsQ2 2024: 215 institutionsQ3 2024: 197 institutionsQ4 2024: 208 institutionsQ1 2025: 234 institutionsQ2 2025: 213 institutionsQ3 2025: 213 institutionsQ4 2025: 218 institutionsQ1 2026: 252 institutionsQ2 2026: 237 institutions
Value heldQ2 2022: $2.20B
Q1 2021: $3.87BQ2 2021: $3.64BQ3 2021: $3.24BQ4 2021: $3.25BQ1 2022: $2.09BQ2 2022: $2.20BQ3 2022: $1.68BQ4 2022: $2.18BQ1 2023: $2.06BQ2 2023: $2.23BQ3 2023: $827.4MQ4 2023: $887.2MQ1 2024: $901.0MQ2 2024: $783.1MQ3 2024: $656.3MQ4 2024: $652.0MQ1 2025: $604.5MQ2 2025: $558.5MQ3 2025: $610.8MQ4 2025: $696.5MQ1 2026: $1.25BQ2 2026: $1.49B
Institutions holding VIR and their total value by quarter
QuarterHoldersValue
Q2 2026237$1.49B
Q1 2026252$1.25B
Q4 2025218$696.5M
Q3 2025213$610.8M
Q2 2025213$558.5M
Q1 2025234$604.5M
Q4 2024208$652.0M
Q3 2024197$656.3M
Q2 2024215$783.1M
Q1 2024210$901.0M
Q4 2023207$887.2M
Q3 2023215$827.4M
Q2 2023227$2.23B
Q1 2023234$2.06B
Q4 2022225$2.18B
Q3 2022221$1.68B
Q2 2022214$2.20B
Q1 2022204$2.09B
Q4 2021210$3.25B
Q3 2021175$3.24B
Q2 2021166$3.64B
Q1 2021157$3.87B

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Vir Biotechnology, Inc.; share changes are against Q1 2022.

Institutions holding VIR in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Pacer Advisors, Inc.784,411$20.0M0.15%+784,139+288,286.4%Added
Northern Trust Corp854,403$21.8M0.00%+243,076+39.8%Added
Morgan Stanley1,081,374$27.5M0.00%+489,696+82.8%Added
Geode Capital Management, LLC1,378,869$35.1M0.01%+133,478+10.7%Added
Bill & Melinda Gates Foundation1,559,142$39.7M30.51%00.0%Unchanged
Alaska Permanent Fund Corp2,300,000$58.6M0.84%00.0%Unchanged
Capital International Investors2,660,682$67.8M0.02%−1,668,834−38.5%Reduced
Alliancebernstein L.P.2,800,537$71.3M0.03%−290,568−9.4%Reduced
Baillie Gifford & Co3,930,852$100.1M0.10%−16,308−0.4%Reduced
State Street Corp5,519,138$140.6M0.01%+1,325,374+31.6%Added
Temasek Holdings (Private) Ltd5,602,553$142.7M0.78%00.0%Unchanged
Vanguard Group Inc8,197,244$208.8M0.01%+438,847+5.7%Added
BlackRock Inc.12,811,690$326.3M0.01%+7,415,506+137.4%Added
SB Investment Advisers (UK) Ltd22,216,644$565.9M4.50%00.0%Unchanged
Taikang Asset Management (Hong Kong) Co Ltd0$00.00%−533,332−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−328,914−100.0%Sold out
Nan Fung Group Holdings Ltd0$00.00%−210,563−100.0%Sold out
Boulder Hill Capital Management LP0$00.00%−126,900−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−61,137−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−47,789−100.0%Sold out
Eaton Vance Management0$00.00%−37,816−100.0%Sold out
Allianz Asset Management GmbH0$00.00%−30,218−100.0%Sold out
HRT Financial LP0$00.00%−25,254−100.0%Sold out
Jump Financial, LLC0$00.00%−24,414−100.0%Sold out
Privium Fund Management B.V.0$00.00%−24,000−100.0%Sold out
Twinbeech Capital LP0$00.00%−21,802−100.0%Sold out
TD Asset Management Inc0$00.00%−21,400−100.0%Sold out
Virtu Financial LLC0$00.00%−21,318−100.0%Sold out
Jackson Creek Investment Advisors LLC0$00.00%−21,070−100.0%Sold out
Cannon Global Investment Management, LLC0$00.00%−20,276−100.0%Sold out
Algert Global LLC0$00.00%−19,465−100.0%Sold out
Corton Capital Inc.0$00.00%−19,098−100.0%Sold out
Crestline Management, LP0$00.00%−16,500−100.0%Sold out
Diametric Capital, LP0$00.00%−15,832−100.0%Sold out
Verition Fund Management LLC0$00.00%−14,090−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−13,555−100.0%Sold out
AXA S.A.0$00.00%−13,400−100.0%Sold out
Delphia (USA) Inc.0$00.00%−13,276−100.0%Sold out
Simplex Trading, LLC0$00.00%−12,364−100.0%Sold out
Group One Trading, L.P.0$00.00%−12,293−100.0%Sold out
Arthur M. Cohen & Associates, LLC0$00.00%−7,276−100.0%Sold out
Seven Eight Capital, LP0$00.00%−11,808−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−8,684−100.0%Sold out
Parametrica Management Ltd0$00.00%−7,823−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−6,835−100.0%Sold out
Quantbot Technologies LP0$00.00%−2,493−100.0%Sold out
Money Concepts Capital Corp0$00.00%−1,726−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−1,200−100.0%Sold out
TCWP LLC0$00.00%−375−100.0%Sold out
Prospera Financial Services Inc0$00.00%−294−100.0%Sold out
Sargent Bickham Lagudis LLC0$00.00%−114−100.0%Sold out
Federated Hermes, Inc.0$00.00%−74−100.0%Sold out
Glassman Wealth Services0$00.00%−1−100.0%Sold out
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed